These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 3339124

  • 1. Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy.
    Sima AA, Nathaniel V, Bril V, McEwen TA, Greene DA.
    J Clin Invest; 1988 Feb; 81(2):349-64. PubMed ID: 3339124
    [Abstract] [Full Text] [Related]

  • 2. Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism.
    Greene DA, Lattimer-Greene S, Sima AA.
    Crit Rev Neurobiol; 1989 Feb; 5(2):143-219. PubMed ID: 2561904
    [Abstract] [Full Text] [Related]

  • 3. Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat.
    Sima AA, Lattimer SA, Yagihashi S, Greene DA.
    J Clin Invest; 1986 Feb; 77(2):474-84. PubMed ID: 3003160
    [Abstract] [Full Text] [Related]

  • 4. Axonal dwindling in early experimental diabetes. II. A study of isolated nerve fibres.
    Jakobsen J.
    Diabetologia; 1976 Dec; 12(6):547-53. PubMed ID: 137158
    [Abstract] [Full Text] [Related]

  • 5. Paranodal structure in diabetic sensory polyneuropathy.
    Thomas PK, Beamish NG, Small JR, King RH, Tesfaye S, Ward JD, Tsigos C, Young RJ, Boulton AJ.
    Acta Neuropathol; 1996 Dec; 92(6):614-20. PubMed ID: 8960320
    [Abstract] [Full Text] [Related]

  • 6. Overt diabetic neuropathy: repair of axo-glial dysjunction and axonal atrophy by aldose reductase inhibition and its correlation to improvement in nerve conduction velocity.
    Sima AA, Prashar A, Nathaniel V, Bril V, Werb MR, Greene DA.
    Diabet Med; 1993 Mar; 10(2):115-21. PubMed ID: 8458187
    [Abstract] [Full Text] [Related]

  • 7. Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies.
    Koike H, Kadoya M, Kaida KI, Ikeda S, Kawagashira Y, Iijima M, Kato D, Ogata H, Yamasaki R, Matsukawa N, Kira JI, Katsuno M, Sobue G.
    J Neurol Neurosurg Psychiatry; 2017 Jun; 88(6):465-473. PubMed ID: 28073817
    [Abstract] [Full Text] [Related]

  • 8. Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol.
    Greene DA, Chakrabarti S, Lattimer SA, Sima AA.
    J Clin Invest; 1987 May; 79(5):1479-85. PubMed ID: 3033025
    [Abstract] [Full Text] [Related]

  • 9. Axonal multifocal neuropathy without conduction block or other features of demyelination.
    Menkes DL.
    Neurology; 2002 Nov 26; 59(10):1666; author reply 1667. PubMed ID: 12451229
    [No Abstract] [Full Text] [Related]

  • 10. Pathology and time relationship of peripheral nerve changes in experimental diabetes.
    Chopra JS, Sawhney BB, Chakravorty RN.
    J Neurol Sci; 1977 May 26; 32(1):53-67. PubMed ID: 140928
    [Abstract] [Full Text] [Related]

  • 11. C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
    Sima AA, Zhang W, Sugimoto K, Henry D, Li Z, Wahren J, Grunberger G.
    Diabetologia; 2001 Jul 26; 44(7):889-97. PubMed ID: 11508275
    [Abstract] [Full Text] [Related]

  • 12. Paranodal dysmyelination in peripheral nerves of Trembler mice.
    Rosenbluth J, Bobrowski-Khoury N.
    J Neurosci Res; 2014 Apr 26; 92(4):476-85. PubMed ID: 24446165
    [Abstract] [Full Text] [Related]

  • 13. Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat.
    Sima AA, Prashar A, Zhang WX, Chakrabarti S, Greene DA.
    J Clin Invest; 1990 May 26; 85(5):1410-20. PubMed ID: 2110189
    [Abstract] [Full Text] [Related]

  • 14. Nodal Na(+)-channel displacement is associated with nerve-conduction slowing in the chronically diabetic BB/W rat: prevention by aldose reductase inhibition.
    Cherian PV, Kamijo M, Angelides KJ, Sima AA.
    J Diabetes Complications; 1996 May 26; 10(4):192-200. PubMed ID: 8835918
    [Abstract] [Full Text] [Related]

  • 15. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry.
    Dyck PJ, Sherman WR, Hallcher LM, Service FJ, O'Brien PC, Grina LA, Palumbo PJ, Swanson CJ.
    Ann Neurol; 1980 Dec 26; 8(6):590-6. PubMed ID: 7212646
    [Abstract] [Full Text] [Related]

  • 16. In vivo evidence of reduced nodal and paranodal conductances in type 1 diabetes.
    Kwai NCG, Arnold R, Poynten AM, Howells J, Kiernan MC, Lin CS, Krishnan AV.
    Clin Neurophysiol; 2016 Feb 26; 127(2):1700-1706. PubMed ID: 26725257
    [Abstract] [Full Text] [Related]

  • 17. Complications: neuropathy, pathogenetic considerations.
    Greene DA, Sima AA, Stevens MJ, Feldman EL, Lattimer SA.
    Diabetes Care; 1992 Dec 26; 15(12):1902-25. PubMed ID: 1464245
    [Abstract] [Full Text] [Related]

  • 18. Supplemental myo-inositol prevents L-fucose-induced diabetic neuropathy.
    Sima AA, Dunlap JA, Davidson EP, Wiese TJ, Lightle RL, Greene DA, Yorek MA.
    Diabetes; 1997 Feb 26; 46(2):301-6. PubMed ID: 9000708
    [Abstract] [Full Text] [Related]

  • 19. Peripheral neuropathy in the WBN/Kob rat with chronic pancreatitis and spontaneous diabetes.
    Yagihashi S, Wada R, Kamijo M, Nagai K.
    Lab Invest; 1993 Mar 26; 68(3):296-307. PubMed ID: 8383778
    [Abstract] [Full Text] [Related]

  • 20. Myelin-associated glycoprotein and myelin galactolipids stabilize developing axo-glial interactions.
    Marcus J, Dupree JL, Popko B.
    J Cell Biol; 2002 Feb 04; 156(3):567-77. PubMed ID: 11827985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.